Endocyte Enters Oversold Territory (ECYT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Wednesday, shares of Endocyte Inc ( ECYT) entered into oversold territory, hitting an RSI reading of 29.96, after changing hands as low as $5.505 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 55.5. A bullish investor could look at ECYT's 29.96 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of ECYT shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Endocyte Inc 1 Year Performance Chart

Looking at the chart above, ECYT's low point in its 52 week range is $5.01 per share, with $9.35 as the 52 week high point — that compares with a last trade of $5.50.

More from Stocks

Tesla Has Lost 15% Since Musk's Take-Private Tweet

Tesla Has Lost 15% Since Musk's Take-Private Tweet

Why Most Americans Like a Volatile Stock Market: Study

Why Most Americans Like a Volatile Stock Market: Study

Should Retirees Invest in the Tech Sector?

Should Retirees Invest in the Tech Sector?

Here's How to Trade Walmart, Nordstrom, Macy's and J.C. Penney After Earnings

Here's How to Trade Walmart, Nordstrom, Macy's and J.C. Penney After Earnings

Dow Trades Higher, Nasdaq Regains Footing as Chipmakers Fall

Dow Trades Higher, Nasdaq Regains Footing as Chipmakers Fall